Top Biotechnology companies in Hong Kong by Revenue

This ranking features the top 11 Biotechnology companies in Hong Kong ranked by Revenue, totalling a Revenue of USD 7.48 B, for January 15, 2025.
#
Name
Revenue
Reported Date
Stock Price
Change
Price (30 days) Country
1
USD 3.69 B
Dec. 31, 2023 USD 0.37 1.03%

Hong Kong

2
USD 2.46 B
Dec. 31, 2023 USD 14.74 7.67%

Hong Kong

3
USD 838.00 M
Dec. 31, 2023 USD 3.02 2.59%

Hong Kong

4
USD 259.86 M
Dec. 31, 2023 USD 0.21 8.82%

Hong Kong

5
USD 155.56 M
Dec. 31, 2023 USD 0.83 3.07%

Hong Kong

6
USD 43.77 M
Dec. 31, 2023 USD 0.10 0.02%

Hong Kong

7
USD 21.74 M
Dec. 31, 2023 USD 5.81 -1.19%

Hong Kong

8
USD 10.64 M
Dec. 31, 2023 USD 0.26 2.03%

Hong Kong

9
USD 397.00 K
Dec. 31, 2023 USD 0.39 0.30%

Hong Kong

10
USD 192.26 K
Dec. 31, 2023 USD 0.13 -1.02%

Hong Kong

11
USD 0.00
June 30, 2024 USD 4.86 -4.71%

Hong Kong

Frequently Asked Questions
  • Which Biotechnology company in Hong Kong has the highest Revenue ?

    The Biotechnology company in Hong Kong with the highest Revenue is Sino Biopharmaceutical Limited (HKSE: 1177.HK) at USD 3.69 B.

  • Which Biotechnology company in Hong Kong has the lowest Revenue ?

    The Biotechnology company in Hong Kong with the lowest Revenue is Regencell Bioscience Holdings Limited (NasdaqCM: RGC) at USD 0.00.